Background. Asthma is a chronic inflammatory illness of the airways characterised by airway obstruction and bronchial hyper-responsiveness that is at least partly reversible. Serial peak expiratory flow measurements are frequently used in the clinical management of asthma to improve diagnose, estimate severity, and screen for provocative variables. When compared to mild persistent asthma, moderate to severe asthma has a lower QOL. Objective. The study’s aim is to determine the impact of Buteyko treatment on asthmatic patients’ peak expiratory flow rate (Expiratory flow rate) and quality of life. Study design. Pre and post type experimental design. Procedure. Twenty-two mild to moderate asthmatic patients, both men and women, aged 25–60 years, were randomly selected and given a peak expiratory flow metre to measure peak expiratory flow rate in the morning and evening at the same time every day. Basic chest physiotherapy was taught to all of the patients. PEFR decreased in 15 of 22 patients throughout the research period, and Buteyko treatment was administered twice daily for 6 weeks. Outcome measures. Peak Expiratory Flow Rate and Questionnaire on Shortness of Breath. Results. With Buteyko therapy, asthmatic patients’ PEFR and Shortness of Breath questionnaires improved statistically significantly (p < 0.05). Conclusion. The study found that Buteyko treatment had a substantial impact on peak expiratory flow rate lowering and asthmatic patients’ quality of life.

Keywords:
dipping, buteyko therapy, quality of life, bronchial asthma, peak expiratory flow rate, shortness of breath questionnaire